Clinical Trial Update: Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE)

View source ↗

Summary

This entry describes the INSPIRE registry, a study to support patients with SARS-CoV-2 infections (COVID-19). The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Myalgic Encephalomyelitis Chronic Fatigue Syndrome
• Neurocognitive Disorders

Snippet

Sponsor: Rush University Medical Center | Conditions: Covid19, ME/CFS | Status: COMPLETED